Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PDUFA
Biotech
FDA delays approval verdict for Exelixis-Tecentriq combo
The three-month delay in the review period was coupled with the FDA asking for updated safety and efficacy data by March 2027.
Marissa Russo
Sep 11, 2026 9:52am
Praxis faces FDA delay, analysts point finger at agency layoffs
Jun 30, 2026 4:13am
FDA delays ruling on AstraZeneca drug after negative adcomm vote
May 27, 2026 4:43am
Aldeyra dry eye disease decision hit by FDA delay
Dec 16, 2025 11:55am
FDA proposes higher fees for ph. 1 trials conducted outside of US
Dec 3, 2025 5:19pm
Denali's Hunter syndrome drug latest to be hit by FDA delay
Oct 14, 2025 8:09am